The Latest Breaking News on Pharma

Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29

Reuters

Benzinga · Sep 29, 2022

DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f

Benzinga · Sep 29, 2022

DGCI allows Serum Institute to export malaria vaccine to U.K.

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

The Hindu · Sep 29, 2022

Lab Monkeys Are the Latest Covid Shortage

Beijing’s ban on macaque exports—needed to test vaccines and other lifesaving drugs—could give its pharma industry an edge.

Businessweek · Sep 28, 2022

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session

Gainers

Benzinga · Sep 28, 2022

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Benzinga · Sep 28, 2022

Lawmakers eye lame duck for unfinished business on insulin

WASHINGTON — A bipartisan Senate duo is still working to pass a bill to overhaul insulin prices, but the outlook is complicated by the messy drug pricing system, politics and a busy congressional calendar.

Tribune News Service · Sep 28, 2022

Opioid crisis cost U.S. nearly $1.5 trillion in 2020 -congressional report

Fueled by the COVID-19 pandemic, the economic toll of the opioid addiction and overdose crisis on the United States reached nearly $1.5 trillion in 2020 alone and is likely to grow, a congressional report seen by Reuters shows.

Reuters · Sep 28, 2022

Pharmaceuticals firm Vectura gets green light for £58m Bristol facility

The Wiltshire-based business specialises in respiratory medicines and inhaler devices

Birmingham Post · Sep 28, 2022

Medicinal cannabis companies fined almost $1m by TGA over false treatment claims

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy

The Guardian - AU · Sep 28, 2022